The annual Conference on Retroviruses and Opportunistic Infections (CROI 2015) took place in Seattle, USA, 23rd-26th February 2015.

Conference highlights


Pre-exposure prophylaxis (PrEP) stops 86% of HIV infections in PROUD study.

Conference bulletins

Read our conference bulletins, in English, French, Italian, Spanish, Portuguese or Russian.

Hepatitis and HIV

Two interferon-free regimens show high HCV cure rates for people with HIV and HCV co-infection.

PrEP: Ipergay

Pre-exposure prophylaxis also stops 86% of HIV infections in Ipergay study.

HIV treatment in Africa

Starting treatment with CD4 above 500 reduces risk of serious illness & death by 44%, African trial shows.

Drug-resistant TB

XDR-TB in South Africa is largely spread person-to-person, not by failure of drug treatment.

Mother-to-child transmission

Seven-country study shows triple-drug combination superior for preventing infant HIV infection.

Conference news

Catch up on the research presented at the conference.

HIV drug in development

HIV maturation inhibitor BMS-955176 looks promising in early study.

aidsmap news from CROI 2015

← First123Next →

Editors' picks from other sources

Email bulletins

Sign up for our conference bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Official conference website

Find out more about the conference and view the program on the official conference website.

Visit the official CROI website >

aidsmap news apps

Keep up to date with the latest HIV news using the free aidsmap news apps for android and iPhone.

Download the app >
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.